The third and final suspect involved in the burglary in Hull has pleaded guilty. Jesse Van Leeuwen was facing the following ...
Ashwini Nadkarni, MD, of Mass General Brigham, discusses how the treatment landscape has changed in recent years for generalized anxiety disorder.
Deputy Gavin St Pier is seeking answers about the scale of prescriptions for medicinal cannabis ...
If you’re like a lot of people, you probably fall short of the recommended seven to nine hours of sleep each night — maybe ...
India approved the world's first fully synthetic CBD oral solution for mild-to-moderate anxiety. Prescription-only, with CBT, it offers a new treatment option after Phase III trials; long-term studies ...
In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.
PsyPost on MSN
Cannabidiol shows no significant benefit for treating psychotic disorders, new study finds
Recent research published in the Journal of Psychopharmacology suggests that cannabidiol, a non-intoxicating compound found ...
Patients with Alzheimer’s disease experienced rapid and significant improvements in agitation with a combination of CBD and ...
Texas will ban delta-8, delta-10, THCP and other hemp products July 31. Here's what remains legal after the Supreme Court ...
The Francis College of Engineering, Department of Mechanical Engineering, invites you to attend a Doctoral Dissertation Mechanical Engineering defense by Alana Griggs entitled, "Advancing Life Cycle ...
"Why would you repeat those damn lies? That destroys trust." -- Sen. Bill Cassidy, MD (R-La.), grilling President Trump's ...
High hopes for those with dementia. New research has found an unexpected benefit for a common symptom in those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results